KIDNEY (RENAL CELL) CANCER

Refine Results:
All Categories Epidemiology and Etiology (150) Prevention and Screening (46) Diagnosis and Staging (251) Treatment (494) Supportive Oncology (31)

CME

Bill Visit 1: A 70-year-old Patient Presenting With Metastatic Renal Cell Carcinoma
An interactive CME program powered by Real CME
OncologySTAT CME

News

Everolimus Shrinks Angiomyolipomas from Tuberous Sclerosis Complex
Elsevier Global Medical News, 2012 Feb 13, S London
Mild CKD Ups Risks of Renal, Urothelial Cancers
Elsevier Global Medical News, 2012 Feb 10, S London
Kidney Cancer Patients May Need Higher Axitinib Dose
Elsevier Global Medical News, 2012 Feb 7, S London
Inlyta Approval Expands Pfizer Kidney Cancer Options, But With Unique Safety Profile
The Pink Sheet Daily, 2012 Jan 27, S Haley
FDA Approves Axitinib for Advanced Kidney Cancer
Elsevier Global Medical News, 2012 Jan 27, E Mechcatie
More News ›

Journal Scans: Research

Methylenetetrahydrofolate Reductase (MTHFR) Gene C677T, A1298C and G1793A Polymorphisms: Association with Risk for Clear Cell Renal Cell Carcinoma and Tumour Behaviour in Men
Clin Oncol, 2012 May 1, MR Safarinejad, et al
Free Journal Content
Cancer Incidence in Patients With Polyglutamine Diseases
Lancet Oncol, 2012 Apr 12, J Ji, et al
Pneumonitis Associated With mTOR Inhibitors Therapy in Patients With Metastatic Renal Cell Carcinoma: Incidence, Radiographic Findings and Correlation With Clinical Outcome
Eur J Cancer, 2012 Apr 5, DA Dabydeen, et al
Free Journal Content
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
J Clin Oncol, 2012 Mar 19, R Motzer, et al
Bisphosphonates Combined With Sunitinib May Improve the Response Rate, Progression Free Survival and Overall Survival of Patients With Bone Metastases From Renal Cell Carcinoma
Eur J Cancer, 2012 Mar 10, D Keizman, et al
More Journal Scans: Research ›

Journal Scans: Review

mTOR Inhibitors in Cancer Therapy
Cancer Lett, 2012 Jun 1, YY Zaytseva, et al
Systemic Therapy for Bone Metastases
Cancer Control, 2012 Apr 19, LS Loftus, et al
Free Journal Content
mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
Hematol Oncol Clin North Am, 2012 Apr 5, A Gomez-Pinillos, et al
Free Journal Content
Defining an Individualized Treatment Strategy for Metastatic Renal Cancer
Urol Clin North Am, 2012 Mar 3, B Hu, et al
Reporting of Myelotoxicity Associated With Emerging Regimens for the Treatment of Selected Solid Tumors
Crit Rev Oncol Hematol, 2012 Feb 1, A Chan, et al
More Journal Scans: Review ›

Expert Opinion

Seminal Articles—Kidney Cancer
2012 Apr 11, Eric Jonasch, et al
SBRT and Spinal Metastasis: Finding Its Niche
Lancet Oncol, 2012 Jan 27, D Schiff, et al
Free Journal Content
Targeted Therapy for Patients With Renal Cell Carcinoma
Lancet Oncol, 2011 Oct 18, BI Rini
Free Journal Content
Approvals for Bevacizumab and Pazopanib Add Options for Advanced Kidney Cancer
Top Stories of 2009, 2010 Jan 1
First-Line Therapy in Advanced RCC: Interview With Robert Motzer, MD
OncologySTAT Editorial Team, 2009 Aug 31, Interview by L Scott Zoeller
More Expert Opinion ›

Chemotherapy Regimens

Temsirolimus (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Sunitinib (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Sorafenib (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Interleukin-2 (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Interferon alfa-2a, interleukin-2 (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

2012 Genitourinary Cancers Symposium
Feb 2-4 2012 San Francisco, et al

Videos

Axitinib Showed Two-Month Advantage To Sorafenib
Elsevier Global Medical News, 2011 Jun 6
Famine to Feast: Many New RCC Options
Community Oncology Conference , 2008 Feb 1, Linda Bosserman MD

Summary of Key Points

Kidney and Ureter
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Kidney (Renal Cell) Cancer

Summary information about kidney (renal cell) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

Cancer Policy Forum

Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.
Read articles ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration